Stryker completes acquisition of neurosurgery company

Stryker completed its acquisition of Nico Corp., a company focused on minimally invasive tumor and intracerebral hemorrhage procedures.

Advertisement

The acquisition expands Stryker’s neurosurgery portfolio, adding Nico’s BrainPath and Myriad products, according to a Sept. 20 news release.

Earlier in September, Stryker finalized its acquisition of care.ai.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.